As mentioned above, given the lack of associations between MBI and tau burden and FDG, the mediation relationships of the two AD biomarkers between MBI and cognitive impairments have not established in the present study (Supplementary Figs. 3 and 4). The gene discussed is MAPT; the disease is Cognitive impairment.